About Us
Vision
R$ Team
R$ Advisory Group
News
Policy & Regulation
Science & Technology
Innovation & Investment
The Short Report
Voices
Conferences & Events
Upcoming Events
Past Events
Partner With Us
Membership
Advertise
Contact
Login
Mentions: Providence Therapeutics
Title
Date
Author
Calgary vaccine developer reaches deal with Manitoba government after hearing no response from Ottawa
February 17, 2021
Mark Lowey
NGen joins $10-million effort to bolster manufacturing capacity for a COVID-19 vaccine
February 3, 2021
Mark Lowey
Precision NanoSystems receives federal support to build $50 million biomanufacturing facility in Vancouver
February 3, 2021
Debbie Lawes
The Short Report – Jan 27, 2021: Clinical trials for first made-in-Canada vaccine begin; a first-of-its-kind carbon capture cement study launches in Edmonton, and more.
January 27, 2021
Cindy Graham
Top
Title
×
TBD
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our
Privacy Policy
and
Terms of Service
.
OK